Microbial Nucleic Acid Detector Gets FDA Class II Designation
Published Date: 5/9/2025
Rule
Summary
The FDA is officially putting a special kind of medical device that spots tiny germs in patient samples into a safer, middle-level category called Class II. This change means the device will follow clear safety rules, helping patients get better access to cool new tech without extra red tape. If you make or use these devices, get ready for updated rules that keep things safe and effective, starting now!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
FISH Microbial Tests Moved to Class II
The FDA is classifying devices that detect and identify microbial nucleic acids by fluorescence in situ hybridization (FISH) in clinical specimens into Class II (special controls). The special controls for this device type will be codified and apply to makers and users of these devices, and the FDA says this step will provide a reasonable assurance of safety and effectiveness.
FDA Says Patient Access to FISH Tests Will Improve
The FDA states that classifying these FISH microbial nucleic acid detection devices into Class II (special controls) will enhance patients' access to beneficial innovative devices by reducing regulatory burdens. The agency says this action provides reasonable assurance of the devices' safety and effectiveness, which is intended to help patient access.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in